Next Article in Journal
Curcumin Derivative CU4c Exhibits HDAC-Inhibitory and Anticancer Activities Against Human Lung Cancer Cells In Vitro and in Mouse Xenograft Models
Next Article in Special Issue
Optimizing Lenvatinib Therapy for Prognostic Improvement in Advanced Thyroid Cancer
Previous Article in Journal
Target Mapping in Cancer: Ligandable Protein Pockets on 3D OncoPPI Networks
Previous Article in Special Issue
Low-Dose Versus Standard-Dose Radioiodine Therapy in Differentiated Thyroid Cancer: Focus on Tolerability in a Retrospective Evaluation
 
 
Review

Article Versions Notes

Pharmaceuticals 2025, 18(7), 959; https://doi.org/10.3390/ph18070959
Action Date Notes Link
article xml file uploaded 26 June 2025 06:38 CEST Original file -
article xml uploaded. 26 June 2025 06:38 CEST Update https://www.mdpi.com/1424-8247/18/7/959/xml
article pdf uploaded. 26 June 2025 06:38 CEST Version of Record https://www.mdpi.com/1424-8247/18/7/959/pdf
article html file updated 26 June 2025 06:39 CEST Original file https://www.mdpi.com/1424-8247/18/7/959/html
Back to TopTop